A carregar...
NK cells specifically TCR-dressed to kill cancer cells
BACKGROUND: Adoptive T-cell transfer of therapeutic TCR holds great promise to specifically kill cancer cells, but relies on modifying the patient's own T cells ex vivo before injection. The manufacturing of T cells in a tailor-made setting is a long and expensive process which could be resolve...
Na minha lista:
| Publicado no: | EBioMedicine |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6413353/ https://ncbi.nlm.nih.gov/pubmed/30665853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.01.031 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|